# Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines

> **NCT04631588** · PHASE1 · COMPLETED · sponsor: **Allergan** · enrollment: 172 (actual)

## Conditions studied

- Facial Fine Lines

## Interventions

- **DRUG:** Botox
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04631588
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-16
- **Primary completion:** 2021-11-03
- **Final completion:** 2021-11-03
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2021-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631588, "Intradermal (ID) BOTOX in the Treatment of Facial Fine Lines". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT04631588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*